What Should You Do With Conduit Pharmaceuticals Inc (NASDAQ: CDT) At Current Prices?

During the last session, Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares were 574.48 million, with the beta value of the company hitting 2.12. At the end of the trading day, the stock’s price was $0.11, reflecting an intraday gain of 16.90% or $0.02. The 52-week high for the CDT share is $7.83, that puts it down -7018.18 from that peak though still a striking 27.27% gain since the share price plummeted to a 52-week low of $0.08. The company’s market capitalization is $11.09M, and the average intraday trading volume over the past 10 days was 7.05 million shares, and the average trade volume was 12.72 million shares over the past three months.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Conduit Pharmaceuticals Inc (CDT) registered a 16.90% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 16.90% in intraday trading to $0.11, hitting a weekly high. The stock’s 5-day price performance is 14.91%, and it has moved by -18.38% in 30 days. Based on these gigs, the overall price performance for the year is -91.70%. The short interest in Conduit Pharmaceuticals Inc (NASDAQ:CDT) is 3.57 million shares and it means that shorts have 0.14 day(s) to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

CDT Dividends

Conduit Pharmaceuticals Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

Conduit Pharmaceuticals Inc insiders own 49.12% of total outstanding shares while institutional holders control 4.06%, with the float percentage being 7.97%.